Search Website
18/07/2018: COGNO ASM Session 8: Adolescent and Young Adult, Paediatric and Rare CNS Tumours

Have you ever wondered how to treat that 35-year-old with a paediatric tumour? Or whether a 17-year-old with a GBM is the same as a 47-year-old? Although most people with a brain tumour have one of the ten most common types, even these are uncommon, and the WHO Classification of Tumours of the Central Nervous System describes over 150 tumours, meaning very rare tumours contribute a significant problem for patients and treating health practitioners. The 2018 COGNO ASM session on Adolescent and Young Adult, Paediatric and Rare CNS Tumours will address some of these challenges with talks from local and international experts who deal with them daily.

17/07/2018: COGNO: items of interest

The following may be of interest to you: Tour de Cure 2019 research funding, Stereotactic Interest Group of Australasia (SIGA) Workshop

5/07/2018: COGNO ASM Session 1: Opening Plenaries 1-3, Abstract deadline extended to 9am Wed 11 July AEST

The central theme of the meeting is 'living well with brain cancer in an era of precision treatments'. Brain tumours are particularly challenging because they can affect a patient in many different and complex ways. This mandates a multi-disciplinary approach to care and the broad expertise of our invited speakers reflects this.

28/06/2018: COGNO ASM - Abstracts and Early Bird Reminder - Deadline Friday 6 July

Call for Abstracts - Submissions will be closing next Friday 6 July 2018!

27/06/2018: COGNO: Up to $3.5M grant funding - call for potential clinical trial proposals by 9am Mon 2 July

Cancer Australia has called for applications for the Contestable Grants Program with funding of up to $3.5million to support clinical trials in primary brain cancer (see below). This is a wonderful opportunity for the neuro-oncology community however timelines are short.

21/06/2018: Reminder: COGNO call for trial concepts for SAC meeting

The next COGNO Scientific Advisory Committee (SAC) meeting is scheduled for Thursday 19 July 2018 and as such, the SAC is calling for submission of potential trial concepts.